ALKERMES | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 9.71B 96M 2025-06
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
ALKERMES USD 297.68M 4.96M 2025-06
Amgen USD 6.52B 337M 2025-06
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
J&J USD 16.8B 8.54B 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Merck USD 9.44B 217M 2025-06
Neurocrine Biosciences USD 541.9M 7M 2025-06
Otsuka Holdings JPY 490.92B 32.5B 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


ALKERMES Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.